Edition:
United States

Ultragenyx Pharmaceutical Inc (RARE.OQ)

RARE.OQ on NASDAQ Stock Exchange Global Select Market

44.02USD
14 Dec 2017
Change (% chg)

$-1.17 (-2.59%)
Prev Close
$45.19
Open
$45.30
Day's High
$45.79
Day's Low
$43.86
Volume
115,525
Avg. Vol
161,893
52-wk High
$91.17
52-wk Low
$43.44

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Daniel Welch

59 2015 Independent Chairman of the Board

Emil Kakkis

57 President, Chief Executive Officer, Director

Shalini Sharp

42 2016 Chief Financial Officer, Executive Vice President

Sunil Agarwal

47 2017 President - Research and Development

Karah Parschauer

39 2016 Executive Vice President, General Counsel